Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts
- PMID: 140943
- DOI: 10.1093/jnci/58.6.1849
Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts
Abstract
Multicellular spheroids of EMT6 mammary sarcoma cells of BALB/c origin were incubated with normal spleen cells or alloimmune spleen cells generated in vitro in mixed leukocyte cultures (MLC). After 24 hours, spheroids were trypsinized and assayed for surviving tumor cells by use of a cloning technique. Under these conditions a 60-80% reduction in clone-forming tumor cells was observed after incubation of spheroids with immune lymphocytes as compared to normal lymphocyte controls. This cytotoxic effect occurred in situ, and alloimmune cells sensitized against unrelated antigens were much less cytotoxic than were specifically sensitized cells. In parallel autoradiographic studies, some immune lymphoid cells that had been labeled with tritiated thymidine during the proliferative phase of the MLC could be demonstrated within spheroids after 24 hours. These results suggested that multicellular spheroids will be a useful in vitro model for more detailed analysis of the factors controlling infiltration in in situ destruction of solid tumor grafts.
Similar articles
-
The multicellular spheroid as a model tumor allograft. I. Quantitative assessment of spheroid destruction in alloimmune mice.Transplantation. 1978 Mar;25(3):136-40. doi: 10.1097/00007890-197803000-00008. Transplantation. 1978. PMID: 644649
-
The multicellular spheroid as a model tumor allograft. II. Characterization of spheroid-infiltrating cytotoxic cells.Transplantation. 1978 Mar;25(3):141-5. doi: 10.1097/00007890-197803000-00009. Transplantation. 1978. PMID: 306146
-
Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model.Cell Immunol. 1984 May;85(2):340-50. doi: 10.1016/0008-8749(84)90248-x. Cell Immunol. 1984. PMID: 6713544
-
Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.Br J Cancer Suppl. 1980 Apr;4:123-7. Br J Cancer Suppl. 1980. PMID: 6932915 Free PMC article.
-
Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.J Immunol. 1975 Nov;115(5):1301-8. J Immunol. 1975. PMID: 51889
Cited by
-
Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis.Bone Res. 2018 Feb 26;6:3. doi: 10.1038/s41413-018-0008-9. eCollection 2018. Bone Res. 2018. PMID: 29507817 Free PMC article. Review.
-
Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo.Tumour Biol. 2016 Feb;37(2):2481-96. doi: 10.1007/s13277-015-4065-z. Epub 2015 Sep 18. Tumour Biol. 2016. PMID: 26385771 Free PMC article.
-
From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.Front Pharmacol. 2018 Feb 14;9:77. doi: 10.3389/fphar.2018.00077. eCollection 2018. Front Pharmacol. 2018. PMID: 29491834 Free PMC article. Review.
-
A multicellular tumor spheroid model of cellular immunity against head and neck cancer.Cancer Immunol Immunother. 1990;32(3):195-200. doi: 10.1007/BF01771457. Cancer Immunol Immunother. 1990. PMID: 2289213 Free PMC article.
-
Effects of α-Mangostin on Viability, Growth and Cohesion of Multicellular Spheroids Derived from Human Breast Cancer Cell Lines.Int J Med Sci. 2018 Jan 1;15(1):23-30. doi: 10.7150/ijms.22002. eCollection 2018. Int J Med Sci. 2018. PMID: 29333084 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources